{"id":"placebo-for-lactoferrin","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert substances used as controls in clinical trials to measure the effect of expectation and psychological factors on patient outcomes. In this case, the placebo is being compared against lactoferrin, an iron-binding protein with potential antimicrobial and immunomodulatory properties. The placebo arm allows researchers to isolate the true pharmacological effects of lactoferrin from psychological and contextual healing effects.","oneSentence":"A placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:54.944Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in lactoferrin clinical trial (indication under investigation)"}]},"trialDetails":[{"nctId":"NCT04966507","phase":"PHASE2","title":"Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2022-02-17","conditions":"Gonorrhea","enrollment":89},{"nctId":"NCT06164600","phase":"PHASE2","title":"Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-06-01","conditions":"Urinary Tract Infections, Recurrent, Child","enrollment":60},{"nctId":"NCT06428357","phase":"NA","title":"Efficacy of Recombinant Bovine Lactoferrin (rbLf) in Iron Regulation","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2024-07-05","conditions":"Exercise Performance","enrollment":92},{"nctId":"NCT05519254","phase":"PHASE3","title":"Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea Sequelae","status":"RECRUITING","sponsor":"University of Washington","startDate":"2023-03-10","conditions":"Diarrhea, Wasting, Malnutrition, Child","enrollment":600},{"nctId":"NCT06984744","phase":"NA","title":"4-day Plaque Accumulation Model Evaluating Compound Containing Gum","status":"RECRUITING","sponsor":"Lactea Therapeutics, LLC","startDate":"2025-06-23","conditions":"Dental Plaque Accumulation","enrollment":32},{"nctId":"NCT07113314","phase":"NA","title":"Prophylaxis of Febrile Neutropenia With Lactoferrin in Oncohematologic Children Undergoing Induction Chemotherapy","status":"COMPLETED","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2016-10-06","conditions":"Febrile Neutropenia (FN), Sepsis, Chemotherapy Treatment","enrollment":160},{"nctId":"NCT06737653","phase":"NA","title":"Palatal Mucosa Wound Healing Following Antimicrobial Gel Application","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Roma La Sapienza","startDate":"2024-12-22","conditions":"Wound Healing, Palate; Wound, Hyaluronic Acid","enrollment":13},{"nctId":"NCT06293911","phase":"NA","title":"Clinical Comparison of a Postbiotic-gel With Placebo Gel for Gingival Inflammation in Patients With Down Syndrome","status":"COMPLETED","sponsor":"University of Pavia","startDate":"2024-03-15","conditions":"Down Syndrome, Gingival Bleeding","enrollment":40},{"nctId":"NCT06704711","phase":"NA","title":"Caffeine Mouth Rinse on Salivary Immunoglobulin A, Lactoferrin and A-Amylase Levels","status":"NOT_YET_RECRUITING","sponsor":"University of Gaziantep","startDate":"2024-11-15","conditions":"Exercise Response","enrollment":30},{"nctId":"NCT05038462","phase":"NA","title":"Fetal Brain Care: Therapies for Brain Neurodevelopment in Fetal Growth Restriction","status":"RECRUITING","sponsor":"Institut d'Investigacions Biomèdiques August Pi i Sunyer","startDate":"2023-01-18","conditions":"Fetal Growth Retardation, Intrauterine Growth Restriction","enrollment":304},{"nctId":"NCT06109688","phase":"PHASE3","title":"Effect of Lactoferrin Supplementation on Urinary Tract Infections in Infants.","status":"COMPLETED","sponsor":"Medical University of Lublin","startDate":"2015-07-01","conditions":"Urinary Tract Infections in Children","enrollment":55},{"nctId":"NCT02968992","phase":"PHASE2","title":"Effects of rhLactoferrin on Chronic Inflammation in the Elderly","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-08-14","conditions":"Inflammation, Cognitive Deterioration","enrollment":36},{"nctId":"NCT05730985","phase":"NA","title":"From the Gut to the Strut: Reducing Inflammation for Healthy Muscles","status":"UNKNOWN","sponsor":"Azienda di Servizi alla Persona di Pavia","startDate":"2022-10-01","conditions":"Inflammation, Sarcopenia, Gut Permeability","enrollment":60},{"nctId":"NCT05669963","phase":"PHASE2, PHASE3","title":"Role of Oral Lactoferrin in Prevention of Recurnt Bacterial Vaginosis in Pregnancy","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2022-07-01","conditions":"Bacterial Vaginosis | Vaginal | Microbiology","enrollment":66},{"nctId":"NCT04621149","phase":"PHASE2","title":"An Outpatient Study Investigating Non-prescription Treatments for COVID-19","status":"TERMINATED","sponsor":"Profact, Inc.","startDate":"2020-11-15","conditions":"COVID-19","enrollment":10},{"nctId":"NCT05283278","phase":"PHASE1","title":"Effect of Administration of Combined Enteral Lactoferrin and Probiotic On Invasive Fungal Infections In Preterm Neonates","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-02-10","conditions":"Fungal Infection","enrollment":80},{"nctId":"NCT02598999","phase":"PHASE1","title":"Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients","status":"TERMINATED","sponsor":"Alaxia SAS","startDate":"2015-11","conditions":"Cystic Fibrosis, Bronchiectasis","enrollment":92},{"nctId":"NCT05151055","phase":"PHASE2","title":"Lactoferrin + Vitamin E + Zinc for Hormonal Acne","status":"UNKNOWN","sponsor":"United Laboratories","startDate":"2020-03-02","conditions":"Hormonal Acne","enrollment":136},{"nctId":"NCT04475120","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients","status":"COMPLETED","sponsor":"University of Rome Tor Vergata","startDate":"2020-04-15","conditions":"Covid19","enrollment":92},{"nctId":"NCT04847791","phase":"NA","title":"Lactoferrin in Covid-19 Hospitalized Patients","status":"UNKNOWN","sponsor":"Paolo Manzoni","startDate":"2021-01-14","conditions":"Covid19","enrollment":194},{"nctId":"NCT04738058","phase":"PHASE1","title":"Influence of Bovine Lactoferrin on Feeding Intolerance and Intestinal Permeability in Preterm Neonates","status":"UNKNOWN","sponsor":"Mansoura University Children Hospital","startDate":"2020-12-15","conditions":"Feeding Intolerance in Preterm, Intestinal Permeability in Preterm","enrollment":60},{"nctId":"NCT03431558","phase":"PHASE3","title":"Bovine Lactoferrin and Neonatal Survival in Low Birth Weight Babies.","status":"UNKNOWN","sponsor":"Aga Khan University","startDate":"2018-05-01","conditions":"Neonatal Sepsis, Necrotizing Enterocolitis","enrollment":300},{"nctId":"NCT03597152","phase":"NA","title":"Nutritional Supplementation for Recurrent Urinary Tract Infections in Women","status":"UNKNOWN","sponsor":"AmPurity Nutraceuticals, LLC","startDate":"2020-08-01","conditions":"Recurrent Urinary Tract Infection","enrollment":250},{"nctId":"NCT03472170","phase":"NA","title":"Clinical Trial for Valuation of the Effectiveness of Lactoferrine in the Prevention of Sepsis in New Premature Born. Bimonitorization of the Antinflammatory Mechanisms, Antioxidants and the Intestinal Microbiote.","status":"UNKNOWN","sponsor":"Maimónides Biomedical Research Institute of Córdoba","startDate":"2017-05-04","conditions":"SEPSIS SYNDROME","enrollment":120},{"nctId":"NCT04094597","phase":"EARLY_PHASE1","title":"Safety and Efficacy of Oral Bovine Lactoferrin","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-01-01","conditions":"Neonatal SEPSIS","enrollment":200},{"nctId":"NCT03490279","phase":"NA","title":"Lactoferrin for the Treatment of Symptomatic Uncomplicated Diverticular Disease","status":"UNKNOWN","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2018-06-01","conditions":"Diverticular Disease, Symptomatic Uncomplicated Diverticular Disease","enrollment":30},{"nctId":"NCT03202615","phase":"PHASE4","title":"Bovine Lactoferrin Versus Ferrous Sulphate In The Treatment Of Iron Deficiency Anemia During Pregnancy","status":"UNKNOWN","sponsor":"Abdelwahed, Mai Mahmoud Mohamed, M.D.","startDate":"2015-09","conditions":"Anemia During Pregnancy","enrollment":130},{"nctId":"NCT02626104","phase":"PHASE2","title":"Bovine Lactoferrin and Antibiotic-associated Diarrhoea.","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2015-12","conditions":"Antibiotic Associated Diarrhoea","enrollment":156},{"nctId":"NCT02925026","phase":"NA","title":"Lactoferrin and Lysozyme Supplementation for Environmental Enteric Dysfunction","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2016-10","conditions":"Environmental Enteric Dysfunction","enrollment":235},{"nctId":"NCT02920125","phase":"PHASE3","title":"Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT.","status":"COMPLETED","sponsor":"Sujata Vaidya","startDate":"2016-01","conditions":"Coronary Artery Disease, Cerebro Vascular Disease, Ischemic Heart Disease","enrollment":96},{"nctId":"NCT01996579","phase":"PHASE2","title":"Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin: The PREVAIL Study","status":"COMPLETED","sponsor":"Queen's University","startDate":"2013-11","conditions":"Critically Ill","enrollment":214},{"nctId":"NCT02959229","phase":"PHASE4","title":"Early Versus Late Lactoferrin in Prevention of Neonatal Sepsis","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2014-08","conditions":"Neonatal Sepsis","enrollment":180},{"nctId":"NCT00509834","phase":"PHASE1, PHASE2","title":"A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia","status":"WITHDRAWN","sponsor":"AM-Pharma","startDate":"2008-07","conditions":"Candidaemia","enrollment":""},{"nctId":"NCT00509847","phase":"PHASE1, PHASE2","title":"A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis","status":"WITHDRAWN","sponsor":"AM-Pharma","startDate":"2009-02","conditions":"Staphylococcal Infections, Bacteremia","enrollment":""},{"nctId":"NCT01821989","phase":"EARLY_PHASE1","title":"Oral Lactoferrin Supplementation for Prevention of Sepsis in Preterm Neonate","status":"UNKNOWN","sponsor":"Mooselmokadem","startDate":"2013-06","conditions":"Neonatal Sepsis","enrollment":180},{"nctId":"NCT00707304","phase":"PHASE3","title":"Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer","status":"COMPLETED","sponsor":"Agennix","startDate":"2008-11","conditions":"Non Small Cell Lung Cancer","enrollment":742},{"nctId":"NCT00854633","phase":"PHASE1, PHASE2","title":"Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants","status":"UNKNOWN","sponsor":"Agennix","startDate":"2009-06","conditions":"Nosocomial Infections","enrollment":120},{"nctId":"NCT01535170","phase":"NA","title":"Bovine Lactoferrin as a Natural Regimen of Selective Decontamination of the Digestive Tract in Patients With Prolonged Mechanical Ventilation","status":"UNKNOWN","sponsor":"China Medical University Hospital","startDate":"2010-09","conditions":"Nosocomial Infections","enrollment":280},{"nctId":"NCT01273779","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis","status":"SUSPENDED","sponsor":"Agennix","startDate":"2011-06","conditions":"Severe Sepsis","enrollment":1280},{"nctId":"NCT00630656","phase":"PHASE2","title":"Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis","status":"COMPLETED","sponsor":"Agennix","startDate":"2008-04","conditions":"Severe Sepsis","enrollment":190},{"nctId":"NCT01382199","phase":"PHASE3","title":"Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients","status":"UNKNOWN","sponsor":"Ventria Bioscience","startDate":"2011-09","conditions":"Diarrhea","enrollment":340}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":201,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo (for Lactoferrin)","genericName":"Placebo (for Lactoferrin)","companyName":"Ain Shams University","companyId":"ain-shams-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect. Used for Control arm in lactoferrin clinical trial (indication under investigation).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}